GTHX

G1 Therapeutics (GTHX)

G1 Therapeutics Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:GTHX

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/28	19:30	GlobeNewswire Inc.	Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)	NASDAQ:GTHX	G1 Therapeutics Inc
2024/05/25	05:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTHX	G1 Therapeutics Inc
2024/05/24	06:06	GlobeNewswire Inc.	G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting	NASDAQ:GTHX	G1 Therapeutics Inc
2024/05/22	23:00	GlobeNewswire Inc.	G1 Therapeutics to Participate in TD Cowen’s 5th Annual Oncology Innovation Summit	NASDAQ:GTHX	G1 Therapeutics Inc
2024/05/22	19:30	GlobeNewswire Inc.	G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses	NASDAQ:GTHX	G1 Therapeutics Inc
2024/05/16	05:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTHX	G1 Therapeutics Inc
2024/05/16	05:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTHX	G1 Therapeutics Inc
2024/05/16	05:07	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTHX	G1 Therapeutics Inc
2024/05/16	05:06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTHX	G1 Therapeutics Inc
2024/05/02	06:50	GlobeNewswire Inc.	G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GTHX	G1 Therapeutics Inc
2024/05/01	19:30	GlobeNewswire Inc.	G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights	NASDAQ:GTHX	G1 Therapeutics Inc
2024/05/01	19:25	GlobeNewswire Inc.	G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib	NASDAQ:GTHX	G1 Therapeutics Inc
2024/04/17	22:00	GlobeNewswire Inc.	G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024	NASDAQ:GTHX	G1 Therapeutics Inc
2024/04/04	23:30	GlobeNewswire Inc.	G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:GTHX	G1 Therapeutics Inc
2024/04/02	05:20	GlobeNewswire Inc.	G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GTHX	G1 Therapeutics Inc
2024/03/02	06:20	GlobeNewswire Inc.	G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:GTHX	G1 Therapeutics Inc
2024/02/28	20:35	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTHX	G1 Therapeutics Inc
2024/02/28	20:30	GlobeNewswire Inc.	G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights	NASDAQ:GTHX	G1 Therapeutics Inc
2024/02/27	22:30	GlobeNewswire Inc.	G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference	NASDAQ:GTHX	G1 Therapeutics Inc
2024/02/15	22:30	GlobeNewswire Inc.	G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024	NASDAQ:GTHX	G1 Therapeutics Inc
2024/02/14	08:14	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTHX	G1 Therapeutics Inc
2024/02/13	06:42	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GTHX	G1 Therapeutics Inc
2024/02/13	06:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTHX	G1 Therapeutics Inc
2024/02/13	06:05	GlobeNewswire Inc.	G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee	NASDAQ:GTHX	G1 Therapeutics Inc
2024/01/10	06:19	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:GTHX	G1 Therapeutics Inc
2024/01/08	20:45	GlobeNewswire Inc.	G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:GTHX	G1 Therapeutics Inc
2024/01/08	20:30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:GTHX	G1 Therapeutics Inc
2024/01/08	20:04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTHX	G1 Therapeutics Inc
2024/01/08	20:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTHX	G1 Therapeutics Inc
2024/01/08	20:03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:GTHX	G1 Therapeutics Inc